pmc.ncbi.nlm.nih.gov
pmc.ncbi.nlm.nih.gov
https://pmc.ncbi.nlm.nih.gov › articles › PMC11087245
The Effects of FABP4 on Cardiovascular Disease in the Aging Population
Elevated FABP4 levels indicate an increased cardiovascular risk and is causally related to acceleration of atherosclerotic disease, However, clinical trials for FABP4 inhibition are lacking, possibly due to concerns about available compounds' side effects. Further research on FABP4 genetics and its putative causal role in cardiovascular disease ...